Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.

ABSTRACT:

Importance

Biologics used for plaque psoriasis have been reported to be associated with an atopic dermatitis (AD) phenotype, or paradoxical eczema, in some patients. The risk factors for this are unknown.

Objective

To explore risk of paradoxical eczema by biologic class and identify factors associated with paradoxical eczema.

Design, setting, and participants

This prospective cohort study used data from the British Association of Dermatologists Biologics and Immunomodulators Register for adults treated with biologics for plaque psoriasis who were seen at multicenter dermatology clinics in the UK and Ireland. Included participants were registered and had 1 or more follow-up visits between September 2007 and December 2022.

Exposures

Duration of exposure to tumor

SUBMITTER: Al-Janabi A 

PROVIDER: S-EPMC10701661 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature